Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Clinical Journal of Oncology Nursing
|
September 15, 2022
Tepotinib: Management of Adverse Events in Patients With MET Exon 14 Skipping Non-Small Cell Lung Cancer
Linda Ahn, Terri Alexander, Soetkin Vlassak, et al.
Sarcoma
|
April 3, 2014
Consumptive coagulopathy in angiosarcoma: a recurrent phenomenon?
Mohamad Farid, Linda Ahn, Andrew Brohl, et al.
The Oncologist
|
January 29, 2014
Malignant peripheral nerve sheath tumors
Mohamad Farid, Elizabeth G Demicco, Roberto Garcia, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 20, 2017
Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas
Juliana B Schilsky, Ai Ni, Linda Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2011
Activity of Sorafenib against desmoid tumor/deep fibromatosis
Mrinal M Gounder, Robert A Lefkowitz, Mary Louise Keohan, et al.
JCO Precision Oncology
|
July 12, 2021
Erlotinib and Trametinib in Patients With <i>EGFR</i>-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor
Jia Luo, Alex Makhnin, Yosef Tobi, et al.
Cancer
|
September 24, 2017
Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases
Kathryn C Arbour, Mark G Kris, Gregory J Riely, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2022
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
Paul K Paik, Pang-Dian Fan, Besnik Qeriqi, et al.
Nature Communications
|
October 14, 2022
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
Paul K Paik, Jia Luo, Ni Ai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 11, 2020
A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers
Paul K Paik, Rachel K Kim, Linda Ahn, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Clinical Journal of Oncology Nursing
|
September 15, 2022
Tepotinib: Management of Adverse Events in Patients With MET Exon 14 Skipping Non-Small Cell Lung Cancer
Linda Ahn, Terri Alexander, Soetkin Vlassak, et al.
Sarcoma
|
April 3, 2014
Consumptive coagulopathy in angiosarcoma: a recurrent phenomenon?
Mohamad Farid, Linda Ahn, Andrew Brohl, et al.
The Oncologist
|
January 29, 2014
Malignant peripheral nerve sheath tumors
Mohamad Farid, Elizabeth G Demicco, Roberto Garcia, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 20, 2017
Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas
Juliana B Schilsky, Ai Ni, Linda Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2011
Activity of Sorafenib against desmoid tumor/deep fibromatosis
Mrinal M Gounder, Robert A Lefkowitz, Mary Louise Keohan, et al.
JCO Precision Oncology
|
July 12, 2021
Erlotinib and Trametinib in Patients With <i>EGFR</i>-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor
Jia Luo, Alex Makhnin, Yosef Tobi, et al.
Cancer
|
September 24, 2017
Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases
Kathryn C Arbour, Mark G Kris, Gregory J Riely, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2022
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
Paul K Paik, Pang-Dian Fan, Besnik Qeriqi, et al.
Nature Communications
|
October 14, 2022
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
Paul K Paik, Jia Luo, Ni Ai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 11, 2020
A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers
Paul K Paik, Rachel K Kim, Linda Ahn, et al.
Page
of 2